{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:19:10Z","timestamp":1791674350079,"version":"4.3.4"},"reference-count":36,"publisher":"The Journal of Rheumatology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"accepted":{"date-parts":[[2025,9,18]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To report the prevalence, incidence and mortality of systemic sclerosis (SSc) in Western Australia (WA).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This was a retrospective observational study, using whole-population linked administrative health data from the WA Rheumatic Disease Epidemiological Registry. All patients with an incident (first-ever) hospitalization with SSc between 1985 and 2013 were identified from discharge diagnosis fields and followed until end of 2014. Outcome measures were incidence rate (IR), point prevalence, standardized mortality ratio (SMR), and survival estimates using Cox regression, stratified by sex.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      In total 877 patients (mean age 58.6 years, 77.8% female, 3.2% Aboriginal and\/or Torres Straits Islander people) had an incident hospitalization for SSc. The age-standardized IR of SSc ranged from 0.44 to 3.26 per 100,000 person-years and point prevalence averaged 37.93 per 100,000 population; both were higher for female individuals. During the study period, 452 (51.5%) patients died with crude mortality higher in male than female patients (66.2% vs 47.4%;\n                      <jats:italic>P<\/jats:italic>\n                      &lt; 0.001). The SMR was 4.17 (95% CI 3.81-4.58), whereas 5- and 10-year survival rates were 67% and 52.4%, respectively. Age (hazard ratio [HR] 1.05, 95% CI 1.04-1.05), male sex (HR 1.56, 95% CI 1.27-1.92), heart failure (HR 1.88, 95% CI 1.36-2.60), kidney disease (HR 1.71, 95% CI 1.13-2.58), and cancer (HR 1.88, 95% CI 1.30-2.74) were independently associated with death. The main causes of death were SSc (n = 128, 28.3%), solid organ malignancy (n = 65, 14.4%), and ischemic heart disease (n = 47; 10.4%).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The burden of SSc in WA exceeds global estimates and its high prevalence, high SMR, and number of deaths due to SSc as a primary cause suggest a large unmet therapeutic need.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3899\/jrheum.2025-0525","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T12:25:20Z","timestamp":1759321520000},"page":"54-61","source":"Crossref","is-referenced-by-count":1,"title":["Long-Term Epidemiology of Systemic Sclerosis in Western Australia: A Population-Level Linked Data Study"],"prefix":"10.3899","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3480-7251","authenticated-orcid":false,"given":"Lauren V.","family":"Host","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0677-0420","authenticated-orcid":false,"given":"Derrick","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8469-2424","authenticated-orcid":false,"given":"Helen I.","family":"Keen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2982-2169","authenticated-orcid":false,"given":"David","family":"Preen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0535-963X","authenticated-orcid":false,"given":"Charles","family":"Inderjeeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2833-7997","authenticated-orcid":false,"given":"Johannes","family":"Nossent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"2026010105290855000_53.1.54.1","doi-asserted-by":"crossref","first-page":"104087","DOI":"10.1016\/j.lpm.2021.104087","article-title":"Pathophysiology of systemic sclerosis","volume":"50","author":"Thoreau","year":"2021","journal-title":"Presse Med"},{"key":"2026010105290855000_53.1.54.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30933-9"},{"key":"2026010105290855000_53.1.54.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.38098"},{"key":"2026010105290855000_53.1.54.4","unstructured":"Avouac J , Denton CP , Matucci-Cerinic M , Chapter 23. Systemic sclerosis: clinical manifestations. In: EULAR textbook on Rheumatic Diseases, 2nd edition. London: BMJ Publishing; 2015:615-29."},{"key":"2026010105290855000_53.1.54.5","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1111\/1756-185X.13203","article-title":"A systematic review of the epidemiology, disease characteristics and management of systemic sclerosis in Australian adults","volume":"20","author":"Morrisroe","year":"2017","journal-title":"Int J Rheum Dis"},{"key":"2026010105290855000_53.1.54.6","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2007.05.003"},{"key":"2026010105290855000_53.1.54.7","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1177\/2397198319873526","article-title":"Prevalence of systemic sclerosis in Colombia: data from the National Health Registry 2012-2016","volume":"5","author":"Fern\u00e1ndez-\u00c1vila","year":"2020","journal-title":"J Scleroderma Relat Disord"},{"key":"2026010105290855000_53.1.54.8","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s13023-021-01733-4","article-title":"Epidemiology of systemic sclerosis: a multi-database population-based study in Tuscany (Italy)","volume":"16","author":"Coi","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"2026010105290855000_53.1.54.9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s00296-020-04720-3","article-title":"Incidence, prevalence and mortality of systemic sclerosis in Italy: a nationwide population-based study using administrative health data","volume":"41","author":"Ciaffi","year":"2021","journal-title":"Rheumatol Int"},{"key":"2026010105290855000_53.1.54.10","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1007\/s12325-022-02078-5","article-title":"Incidence rate and prevalence of systemic sclerosis and systemic sclerosis-associated interstitial lung disease in Japan: analysis using Japanese claims databases","volume":"39","author":"Kuwana","year":"2022","journal-title":"Adv Ther"},{"key":"2026010105290855000_53.1.54.11","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s10067-018-4182-3","article-title":"The incidence, prevalence, and survival of systemic sclerosis in the UK Clinical Practice Research Datalink","volume":"37","author":"Royle","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2026010105290855000_53.1.54.12","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1111\/1756-185X.13716","article-title":"Prevalence and incidence of systemic sclerosis: a systematic review and meta-analysis","volume":"22","author":"Zhong","year":"2019","journal-title":"Int J Rheum Dis"},{"key":"2026010105290855000_53.1.54.13","doi-asserted-by":"publisher","DOI":"10.1046\/j.1445-5994.2001.00048.x"},{"key":"2026010105290855000_53.1.54.14","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1445-5994.1999.tb01587.x","article-title":"Systemic sclerosis prevalence and mortality in Sydney 1974-1988","volume":"1","author":"Englert","year":"1999","journal-title":"Aust N Z J Med"},{"key":"2026010105290855000_53.1.54.15","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcp174"},{"key":"2026010105290855000_53.1.54.16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s41927-018-0043-6","article-title":"Trends in incidence, mortality, and causes of death associated with systemic sclerosis in Denmark between 1995 and 2015: a nationwide cohort study","volume":"2","author":"Butt","year":"2018","journal-title":"BMC Rheumatol"},{"key":"2026010105290855000_53.1.54.17","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S191418"},{"key":"2026010105290855000_53.1.54.18","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.114264"},{"key":"2026010105290855000_53.1.54.19","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/BOR.0000000000000785","article-title":"Scleroderma epidemiology update","volume":"33","author":"Calderon","year":"2021","journal-title":"Curr Opin Rheumatol"},{"key":"2026010105290855000_53.1.54.20","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-021-02672-y"},{"key":"2026010105290855000_53.1.54.21","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-2080-y"},{"key":"2026010105290855000_53.1.54.22","doi-asserted-by":"publisher","DOI":"10.1186\/s41927-022-00324-5"},{"key":"2026010105290855000_53.1.54.23","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1111\/j.1753-6405.1995.tb00439.x","article-title":"Record linkage in Australian epidemiological research: health benefits, privacy safeguards and future potential","volume":"19","author":"Sibthorpe","year":"1995","journal-title":"Aust J Public Health"},{"key":"2026010105290855000_53.1.54.24","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1002\/acr2.11540","article-title":"Risk of major adverse cardiovascular event following incident hospitalization for acute gout: a Western Australian population-level linked data study","volume":"5","author":"Lopez","year":"2023","journal-title":"ACR Open Rheumatol"},{"key":"2026010105290855000_53.1.54.25","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000182534.19832.83"},{"key":"2026010105290855000_53.1.54.26","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keab190"},{"key":"2026010105290855000_53.1.54.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2004.04.031"},{"key":"2026010105290855000_53.1.54.28","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-019-1867-1"},{"key":"2026010105290855000_53.1.54.29","doi-asserted-by":"crossref","first-page":"102494","DOI":"10.1016\/j.autrev.2020.102494","article-title":"Gender-related differences in systemic sclerosis","volume":"19","author":"Hughes","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2026010105290855000_53.1.54.30","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1007\/s10067-013-2289-0","article-title":"Mortality in systemic sclerosis-a single centre study from the UK","volume":"32","author":"Strickland","year":"2013","journal-title":"Clin Rheumatol"},{"key":"2026010105290855000_53.1.54.31","doi-asserted-by":"crossref","first-page":"102633","DOI":"10.1016\/j.autrev.2020.102633","article-title":"Association between systemic sclerosis and risk of lung cancer: results from a pool of cohort studies and Mendelian randomization analysis","volume":"19","author":"Peng","year":"2020","journal-title":"Autoimmun Rev"},{"key":"2026010105290855000_53.1.54.32","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209775"},{"key":"2026010105290855000_53.1.54.33","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.200737"},{"key":"2026010105290855000_53.1.54.34","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1093\/rheumatology\/kez532","article-title":"The clinical and economic burden of systemic sclerosis related interstitial lung disease","volume":"59","author":"Morrisroe","year":"2020","journal-title":"Rheumatology"},{"key":"2026010105290855000_53.1.54.35","doi-asserted-by":"publisher","DOI":"10.1097\/01.mlr.0000228018.48783.34"},{"key":"2026010105290855000_53.1.54.36","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/1756-185X.14036","article-title":"Cancer diagnosis and mortality in patients with ankylosing spondylitis: a Western Australian retrospective cohort study","volume":"24","author":"Kelty","year":"2021","journal-title":"Int J Rheum Dis"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.2025-0525","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T13:29:47Z","timestamp":1767274187000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.2025-0525"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,1,1]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.3899\/jrheum.2025-0525"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.2025-0525","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}